Lv4
526 积分 2025-10-10 加入
Comparative efficacy of 11 non-pharmacological interventions on depression, anxiety, quality of life, and caregiver burden for informal caregivers of people with dementia: A systematic review and network meta-analysis
6天前
已完结
Comparative efficacy, safety, and acceptability of pimavanserin and other atypical antipsychotics for parkinson's disease psychosis: Systematic review and network meta-analysis
6天前
已完结
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
9天前
已完结
A New Hope in Alzheimer's Disease Psychosis: Pimavanserin
10天前
已完结
Pimavanserin and dementia-related psychosis
10天前
已关闭
Pharmacological treatment of anxiety in older adults: a systematic review and meta-analysis
16天前
已完结
Pimavanserin for psychosis in Parkinson's disease dementia: Subgroup analysis of the HARMONY Trial
16天前
已关闭
Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe
16天前
已完结
Pimavanserin Exposure-Response Analyses in Patients With Schizophrenia
16天前
已完结
皖公网安备34019202002308
